Celiprolol Treatment in Patients with Vascular Ehlers-Danlos Syndrome.

European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
Hassan BaderkhanMartin Björck


Vascular Ehlers-Danlos syndrome (vEDS) is a rare monogenetic disease caused by pathogenic variants in procollagen 3A1. Arterial rupture is the most serious clinical manifestation. A randomised controlled trial, the Beta-Blockers in Ehlers-Danlos Syndrome Treatment (BBEST) trial, reported a significant protective effect of the beta blocker celiprolol. The aim was to study the outcome of celiprolol treatment in a cohort of Swedish patients with vEDS. Uppsala is a national referral centre for patients with vEDS. They are assessed by vascular surgeons, angiologists, and clinical geneticists. Family history, previous and future clinical events, medication, and side effects are registered. Celiprolol was administered twice daily and titrated up to a maximum dose of 400 mg daily. Logistic regression was used to analyse predictors of vascular events. Forty patients with pathogenic sequence variants in COL3A1 were offered treatment with celiprolol in the period 2011-2019. The median follow up was 22 months (range 1-98 months); total follow up was 106 patient years. In two patients, uptitration of the dose is ongoing. Of the remaining 38, 26 (65%) patients reached the target dose of 400 mg daily. Dose uptitration was unsuccessful in six ...Continue Reading


Jan 1, 1986·Journal of Clinical Pharmacology·F S CarusoR Vukovich
Mar 9, 2000·The New England Journal of Medicine·Melanie PepinPeter H Byers
Aug 16, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Stephan RosenkranzMichael Böhm
Mar 10, 2004·Circulation·Pierre BoutouyrieStéphane Laurent
Jul 14, 2005·Journal of Vascular Surgery·Gustavo S OderichPeter Gloviczki
Dec 2, 2006·Gynecologic and Obstetric Investigation·Martin BjörckD Bergqvist
Nov 22, 2008·Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi·Atsushi Watanabe, Takashi Shimada
Jan 27, 2010·The Journal of Clinical Investigation·Harry C Dietz
Apr 17, 2010·American Journal of Hypertension·Kai MortensenYskert von Kodolitsch
Oct 23, 2013·Canadian Journal of Physiology and Pharmacology·Mohammed Amine AbdelkrimMohamed Yassine Mallem
Jun 13, 2014·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Mitzi L MurrayPeter H Byers
Nov 5, 2015·Journal of Hypertension·Giuseppe Schillaci, Giacomo Pucci
Mar 18, 2017·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Peter H ByersNigel Wheeldon
Dec 12, 2018·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·Anders WanhainenHence Verhagen
Apr 20, 2019·Journal of the American College of Cardiology·Michael FrankXavier Jeunemaitre
Apr 20, 2019·Journal of the American College of Cardiology·Julie De Backer, Tine De Backer


Nov 24, 2020·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·James Kelly, Oliver Lyons

Related Concepts

Elderly (population group)
Dose-Response Relationship, Drug
Drug Administration Schedule
Ehlers-Danlos Syndrome, Type IV
Feasibility Studies
Follow-Up Studies
Homo sapiens

Related Feeds


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.